|
99
|
236
|
6rl3A |
Fragment az-003 binding at the p53pt387/14-3-3 sigma interface |
|
101
|
236
|
6rkiA |
Fragment az-023 binding at the p53pt387/14-3-3 sigma interface |
|
0
|
10
|
6r5lP |
Fragment az-006 binding at the p53pt387/14-3-3 sigma interface |
|
98
|
236
|
6rkkA |
Fragment az-021 binding at the p53pt387/14-3-3 sigma interface |
|
0
|
13
|
6rhcP |
Fragment az-003 binding at the tazps89/14-3-3 sigma interface |
|
0
|
12
|
6rl6P |
Fragment az-024 binding at the p53pt387/14-3-3 sigma interface |
|
0
|
12
|
6rl4P |
Fragment az-025 binding at the p53pt387/14-3-3 sigma interface |
|
0
|
10
|
6rkkP |
Fragment az-021 binding at the p53pt387/14-3-3 sigma interface |
|
100
|
236
|
6rl4A |
Fragment az-025 binding at the p53pt387/14-3-3 sigma interface |
|
0
|
12
|
6rl3P |
Fragment az-003 binding at the p53pt387/14-3-3 sigma interface |
|
100
|
236
|
6rkmA |
Fragment az-022 binding at the p53pt387/14-3-3 sigma interface |
|
0
|
10
|
6qiuP |
Crystal structure of 14-3-3 sigma in complex with ataxin-1 ser776 phosphopeptide |
|
98
|
236
|
6qhlA |
14-3-3 sigma with rela/p65 binding site ps45 |
|
98
|
236
|
6nv2A |
14-3-3 sigma with rela/p65 binding site ps45 in complex with dp005 |
|
94
|
236
|
6tjmA |
Crystal structure of an estrogen receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma stabilized by pyrrolidone1 |
|
93
|
236
|
6tl3A |
Crystal structure of an estrogen receptor alpha 8-mer phosphopeptide in complex with 14-3-3sigma stabilized by a pyrrolidone1 derivative |
|
95
|
234
|
6w0lA |
Henipavirus w protein interacts with 14-3-3 to modulate host gene expression |
|
87
|
236
|
6tlfA |
Human 14-3-3 sigma isoform in complex with imp |
|
93
|
236
|
6tlgA |
Ligand-free state of human 14-3-3 sigma isoform |
|
86
|
236
|
6tm7A |
Human 14-3-3 sigma isoform in complex with plp |
|
99
|
236
|
6y1jA |
14-3-3 sigma in complex with ikappabalpha ps63 peptide |
|
96
|
236
|
6qduA |
Crystal structure of 14-3-3sigma in complex with a rapgef2 pt740 phosphopeptide inhibited by semi-synthetic fusicoccane fc-ncpc |
|
101
|
236
|
6qdtA |
Crystal structure of 14-3-3sigma in complex with a rapgef2 pt740 phosphopeptide |
|
100
|
236
|
6qdsA |
Crystal structure of 14-3-3sigma in complex with a pak6 pt99 phosphopeptide stabilized by semi-synthetic fusicoccane fc-ncpc |
|
97
|
236
|
6qdrA |
Crystal structure of 14-3-3sigma in complex with a pak6 pt99 phosphopeptide |
|
100
|
236
|
6qzsA |
14-3-3 sigma in complex with foxo1 ps256 peptide |
|
94
|
236
|
6qzrA |
14-3-3 sigma in complex with foxo1 pt24 peptide |
|
0
|
9
|
6g6xP |
14-3-3sigma in complex with a p129beta3p mutated yap ps127 phosphopeptide |
|
0
|
8
|
5n5tP |
14-3-3 sigma in complex with taz ps89 peptide and fragment nv2 |
|
0
|
10
|
5n75P |
14-3-3 sigma in complex with taz ps89 peptide |
|
0
|
10
|
5n5wP |
14-3-3 sigma in complex with taz ps89 peptide and fragment nv3 |
|
0
|
9
|
5n5rP |
14-3-3 sigma in complex with taz ps89 peptide and fragment nv1 |
|
0
|
6
|
4y3bD |
Crystal structure of c-terminal modified tau peptide-hybrid 201d with 14-3-3sigma |
|
0
|
8
|
4fl5P |
Crystal structure of human 14-3-3 sigma in complex with a tau-protein peptide surrounding ps214 |
|
102
|
236
|
6hkbA |
Ternary complex of estrogen receptor alpha peptide and 14-3-3 sigma c42 mutant bound to disulfide fragment ppi stabilizer 3 |
|
101
|
236
|
6hmtA |
Ternary complex of estrogen receptor alpha peptide and 14-3-3 sigma c42 mutant bound to disulfide fragment ppi stabilizer 2 |
|
99
|
236
|
6hmuA |
Ternary complex of estrogen receptor alpha peptide and 14-3-3 sigma c45 mutant bound to disulfide fragment ppi stabilizer 6 |
|
103
|
236
|
6hkfA |
Ternary complex of estrogen receptor alpha peptide and 14-3-3 sigma c42 mutant bound to disulfide fragment ppi stabilizer 4 |
|
102
|
236
|
6hn2A |
Ternary complex of estrogen receptor alpha peptide and 14-3-3 sigma c42 mutant bound to disulfide fragment ppi stabilizer 5 |
|
101
|
236
|
6hhpA |
Ternary complex of estrogen receptor alpha peptide and 14-3-3 sigma c42 mutant bound to disulfide fragment ppi stabilizer 1 |
|
99
|
236
|
6g8pA |
14-3-3sigma in complex with a p129beta3p and l132beta3l mutated yap ps127 phosphopeptide |
|
99
|
236
|
6g8iA |
14-3-3sigma in complex with a r124beta3r mutated yap ps127 phosphopeptide |
|
97
|
236
|
6g6xA |
14-3-3sigma in complex with a p129beta3p mutated yap ps127 phosphopeptide |
|
100
|
236
|
6g8jA |
14-3-3sigma in complex with a a130beta3a mutated yap ps127 phosphopeptide |
|
99
|
236
|
6g8kA |
14-3-3sigma in complex with a s131beta3s mutated yap ps127 phosphopeptide |
|
101
|
236
|
6g8lA |
14-3-3sigma in complex with a l132beta3l mutated yap ps127 phosphopeptide |
|
0
|
9
|
6g8iP |
14-3-3sigma in complex with a r124beta3r mutated yap ps127 phosphopeptide |
|
98
|
236
|
6g8qA |
14-3-3sigma in complex with a a130beta3a and q133beta3q mutated yap ps127 phosphopeptide |
|
99
|
236
|
5my9A |
Crystal structure of human 14-3-3 sigma in complex with lrrk2 peptide ps935 |
|
100
|
236
|
5mxoA |
Crystal structure of 14-3-3sigma and a p53 c-terminal 12-mer synthetic phosphopeptide stabilized by fusicoccin-a |
